Monograph Title | Section | Source Publication | Page Number | Errata Post Date Sort ascending | Errata Official Date | Target Errata Print Publication | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
MUPIROCIN CREAM | Related compounds/Table 1 | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In footnote 2: Change 9-{(E)-4-[(2R,3aS,6S,7S,8aRS)-2-{(1RS,2S,3S)-1,3-Dihydroxy-2-methylbutyl}-7-hydroxyhexahydro-2H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyloxy}nonanoic acid. to:… Read More |
BROMOCRIPTINE MESYLATE CAPSULES | PERFORMANCE TESTS/Dissolution <711> | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In Analysis: Change bromocriptine mesylate (C32H40BrN5O5 · CH4SO3) to: bromocriptine (C32H40BrN5O5) AND In… Read More |
DACARBAZINE FOR INJECTION | IDENTIFICATION | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | Delete Identification test C |
MUPIROCIN CALCIUM | IMPURITIES/Organic Impurities/Table 1 | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In footnote b: Change 9-{(E)-4-[(2R,3aS,6S,7S,8aRS)-2-{(1RS,2S,3S)-1,3-Dihydroxy-2-methylbutyl}-7-hydroxyhexahydro-2H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyloxy}nonanoic acid. to:… Read More |
ONDANSETRON ORAL SOLUTION | USP Reference standards <11> | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | Change USP Ondansetron Related Compound A RS 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride. USP Ondansetron Related Compound C RS 1,2,3,9-Tetrahydro-9-methyl-4H-carbazol-4-one. USP… Read More |
ACYCLOVIR FOR INJECTION | IMPURITIES/Procedure | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | In Standard solution A: Change 0.5 μg/mL of Acyclovir standard solution in Solution A to: 0.5 μg/mL of USP Acyclovir RS from Acyclovir standard solution in Solution A AND In Standard solution B:… Read More |
<621> CHROMATOGRAPHY | SYSTEM SUITABILITY | USPNF Online | Online | 25-Mar-2022 | 1-Dec-2022 | NA | NA | Change System Repeatability—Assay of an Active Substance or an Excipient to: System Repeatability |
DIBASIC POTASSIUM PHOSPHATE | ASSAY/Procedure | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | In Analysis: Change Titrate the Blank with 1 N sodium hydroxide VS, and record the volume of 1 N sodium hydroxide VS consumed. Titrate the excess acid in the Sample solution with 1 N sodium hydroxide VS to the inflection point at pH 4, and… Read More |
ONDANSETRON TABLETS | IMPURITIES/Organic Impurities | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | In Table 1/footnotes: Change b1,2,3,9-Tetrahydro-9-methyl-4H-carbazol-4-one. c1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one. d3[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one. … Read More |
POWDERED VALERIAN EXTRACT | DEFINITION | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | Change calculated as the sum of hydroxyvalerenic acid, acetoxyvalerenic acid, and valerenic acid, on the dried basis. to: calculated as the sum of hydroxyvalerenic acid, acetoxyvalerenic acid, and valerenic acid, on the anhydrous basis. |
PANTOPRAZOLE SODIUM | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | In USP Pantoprazole Related Compound E RS: Change A mixture of the stereoisomers of 6,6′-bis(difluoromethoxy)-2,2′-bis[[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl]-1H,1′H-5,5′-bibenzimidazolyl. to: 6,6′-Bis(difluoromethoxy)-2,2′-bis[[(3,4-… Read More |
CORN STARCH | IMPURITIES/Limit of Sulfur Dioxide | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | In Bromophenol blue indicator solution: Change 0.2 mg/mL of bromophenol blue in dilute alcohol. Filter if necessary. to: Dissolve 100 mg of bromophenol blue in 100 mL of dilute alcohol (1 in 5), and filter if necessary. |
ONDANSETRON TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | Change USP Ondansetron Related Compound A RS 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride. to: USP Ondansetron Related Compound A RS 3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H… Read More |
POWDERED VALERIAN EXTRACT | COMPOSITION/Content of Valerenic Acids | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | In Acceptance criteria: Change calculated as the sum of hydroxyvalerenic acid, acetoxyvalerenic acid, and valerenic acid on the dried basis to: calculated as the sum of hydroxyvalerenic acid, acetoxyvalerenic acid, and valerenic acid on the anhydrous… Read More |
MAGNESIUM OXIDE | IMPURITIES/Limit of Calcium | USPNF Online | Online | 25-Feb-2022 | 1-Dec-2022 | NA | NA | In Analysis: Change CU = concentration of Magnesium Hydroxide in the Sample solution (mg/mL) to: CU = concentration of Magnesium Oxide in the Sample solution (mg/mL) |
IODIXANOL | IMPURITIES/Limit of 2-Methoxyethanol | USPNF Online | Online | 25-Feb-2022 | 1-Mar-2022 | NA | NA | In Standard stock solution: Change 0.005 mg/mL of methanol and 0.01 mg each of isopropyl alcohol, secondary butyl alcohol, and 2-methoxyethanol in Internal standard solution to: 0.005 mg/mL of methanol and 0.01 mg/mL each of isopropyl… Read More |
PROPYLENE GLYCOL DIACETATE | IMPURITIES/Organic Impurities | USPNF Online | Online | 25-Feb-2022 | 1-Mar-2022 | NA | NA | In Analysis: Change rS = sum of all the peak areas, excluding the solvent peaks from the Standard solution to: rS = sum of all the peak areas, excluding the solvent peaks from the Sample solution… Read More |
ZOLEDRONIC ACID | IMPURITIES/Organic Impurities | USPNF Online | Online | 25-Feb-2022 | 1-Mar-2022 | NA | NA | In Analysis: Change rU = peak response of zoledronic acid from the Sample solution to: rU = peak response of any individual impurity from the Sample solution |
ECONAZOLE NITRATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 25-Feb-2022 | 1-Mar-2022 | NA | NA | In USP Econazole Related Compound B RS: Change Econazole amine; 2-[(4-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethanamine. C15H14Cl3NO 330.64 to: Econazole amine; 2-[(4-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)… Read More |
TRAZODONE HYDROCHLORIDE TABLETS | IMPURITIES/Organic Impurities | USPNF Online | Online | 25-Feb-2022 | 1-Mar-2022 | NA | NA | In footnote f of Table 2: Change 1,1-Bis{2-chloro-[4-(3-{1,2,4-triazolo[4,3-a]pyridin-3-(2H)-on-2-yl}propyl)piperazine-1-yl]phenyl}ethane trihydrochloride. to: 2,2'-{[Ethane-1,1-diylbis(3-chloro-4,1-phenylene)bis(piperazine-4,1-diyl)]bis(… Read More |
BEHENOYL POLYOXYLGLYCERIDES | SPECIFIC TESTS/Fats and Fixed Oils, Hydroxyl Value <401> | USPNF Online | Online | 25-Feb-2022 | 1-Mar-2022 | NA | NA | In Analysis: Change If the volume of 0.5 N sodium hydroxide VS required for the titration is less than 2 mL, to: If the volume of 0.5 N alcoholic potassium hydroxide VS required for the titration is less than 2 mL, |
ONDANSETRON ORALLY DISINTEGRATING TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | In USP Ondansetron Related Compound A RS: Change 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride. C16H20N2O · HCl 292.80 to: 3-[(Dimethylamino)methyl]-9-methyl-1,2,… Read More |
LEVOFLOXACIN | IMPURITIES/Organic Impurities, Procedure 1 | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | Change Solution A, Mobile phase, Sample solution, and Chromatographic system: Proceed as directed in the Assay. to: Buffer, Mobile phase, Sample solution, and Chromatographic system:… Read More |
FULVESTRANT | Related compounds | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | In footnote 1 of table: Change Estra-1,3,5(10)-triene-6-one-3,17-diol,7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-(7α,17β) to: 7α-{9-[(4,4,5,5,5,-Pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-6-one-3,17β-diol AND In footnote 2: Change… Read More |
ONDANSETRON HYDROCHLORIDE | USP Reference standards <11> | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | In USP Ondansetron Related Compound A RS: Change 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride. to: 3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride. AND… Read More |
WARFARIN SODIUM FOR INJECTION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | In USP Warfarin Related Compound A RS: Change 3-(o-Hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one. to: 3-(2-Hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one. AND Change 264.33 to: 264.32 |
SORAFENIB TABLETS | PERFORMANCE TESTS/Dissolution <711> | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | In Tolerances: Change NLT 75 (Q) of the labeled amount of sorafenib (C21H16ClF3N4O3) is dissolved. to: NLT 75% (Q) of the labeled amount of sorafenib (C21H16… Read More |
ORPHENADRINE CITRATE INJECTION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | In USP Orphenadrine Related Compound B RS: Change N-Ethyl-N,N-dimethyl [2-2(methylbenzhydryloxy)ethyl]ammonium chloride; also known as N-ethyl-N,N-dimethyl-2-[phenyl(o-tolyl)methoxy]ethanaminium… Read More |
NICARDIPINE HYDROCHLORIDE INJECTION | DEFINITION | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | Change NTL 90.0% to: NLT 90.0% |
AMLODIPINE BESYLATE | Assay | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | In Chromatographic system: Change Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the standard deviation for replicate injections is not more than 2.0%. to: Chromatograph the … Read More |
ONDANSETRON INJECTION | USP Reference standards <11> | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | In USP Ondansetron Related Compound A RS: Change 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride. to: 3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride. AND… Read More |
LORATADINE CAPSULES | PERFORMANCE TESTS/Dissolution <711> | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | In Tier 1/Solution A and Tier 2/Solution B: Change Tween 20 to: polysorbate 20 |
FULVESTRANT | CHEMICAL INFORMATION | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | Change 606.77 to: 606.78 |
ORPHENADRINE CITRATE EXTENDED-RELEASE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | In USP Orphenadrine Related Compound B RS: Change N-Ethyl-N,N-dimethyl [2-2(methylbenzhydryloxy)ethyl]ammonium chloride; Also known as N-Ethyl-N,N-dimethyl-2-[phenyl(o-tolyl)methoxy]ethanaminium… Read More |
WARFARIN SODIUM TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | In USP Warfarin Related Compound A RS: Change 3-(o-Hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one. to: 3-(2-Hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one. AND Change 264.33 to: 264.32 |
AMLODIPINE BESYLATE | Related compounds/Test 2 | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | In Chromatographic system: Change Chromatograph the Standard solution, and record the peak responses as directed for Procedure: the standard deviation for replicate injections is not more than 10.0%. to: Chromatograph the … Read More |
ONDANSETRON | USP Reference standards <11> | USPNF 2021 ISSUE 1 | Online | 31-Dec-2021 | 1-Jan-2022 | NA | NA | Change USP Ondansetron RS USP Ondansetron Related Compound C RS 1,2,3,9-Tetrahydro-9-methyl-4H-carbazol-4-one. USP Ondansetron Related Compound D RS 1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one. to: USP… Read More |
CARBOPLATIN FOR INJECTION | IMPURITIES/Limit of 1,1-Cyclobutanedicarboxylic Acid | USPNF 2021 ISSUE 1 | Online | 31-Dec-2021 | 1-Jan-2022 | NA | NA | In Chromatographic system/Column: Change 4.0-mm × 30-cm; packing L1 to: 3.9-mm × 30-cm; packing L1 |
CALCIUM SACCHARATE | ASSAY/Procedure | USPNF 2021 ISSUE 1 | Online | 31-Dec-2021 | 1-Jan-2022 | NA | NA | In Analysis: Change Result = {[(VS − VB) × N × F]/W} × 100 to: Result = {[(VS − VB) × M × F]/W} × 100 AND Change … Read More |
EXTENDED PHENYTOIN SODIUM CAPSULES | ASSAY/Procedure | Revision Bulletin (Official March 01, 2021) | Online | 31-Dec-2021 | 1-Jan-2022 | NA | NA | In Sample solution: Change Nominally 0.6 mg/mL of phenytoin to: Nominally 0.6 mg/mL of phenytoin sodium AND In Analysis: Change CU = nominal concentration of phenytoin in the Sample solution (mg/mL) to… Read More |
CARBOPLATIN | IMPURITIES/Limit of 1,1-Cyclobutanedicarboxylic Acid | USPNF 2021 ISSUE 1 | Online | 31-Dec-2021 | 1-Jan-2022 | NA | NA | In Chromatographic system/Column: Change 4.0-mm × 30-cm; packing L1 to: 3.9-mm × 30-cm; packing L1 |
SUCCINYLCHOLINE CHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 1 | Online | 31-Dec-2021 | 1-Jan-2022 | NA | NA | In USP Succinylmonocholine Chloride RS: Change Ethanaminium, 2-(carboxy-1-oxopropoxy)-N,N,N-trimethyl-, chloride. to: Ethanaminium, 2-(3-carboxy-1-oxopropoxy)-N,N,N-trimethyl-, chloride; Also… Read More |
ATORVASTATIN CALCIUM | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 1 | Online | 31-Dec-2021 | 1-Jan-2022 | NA | NA | In USP Atorvastatin Related Compound C RS: Change C66H66F4N4O10 to: C66H66CaF4N4O10 AND In USP Atorvastatin Related Compound E RS: Change… Read More |
EXTENDED PHENYTOIN SODIUM CAPSULES | IMPURITIES/Organic Impurities | Revision Bulletin (Official March 01, 2021) | Online | 31-Dec-2021 | 1-Jan-2022 | NA | NA | In both Calculations in Analysis: Change CU = nominal concentration of phenytoin in the Sample solution (µg/mL) to: CU = nominal concentration of phenytoin sodium in the Sample solution (µg/mL) |
PRAZOSIN HYDROCHLORIDE | IMPURITIES/Organic Impurities | USPNF 2021 ISSUE 1 | Online | 31-Dec-2021 | 1-Jan-2022 | NA | NA | In Sensitivity solution: Change 0.05 µg/mL of USP Prazosin Hydrochloride RS in Mobile phase from the Standard solution to: 0.5 µg/mL of USP Prazosin Hydrochloride RS in Mobile phase from the Standard solution |
CAPTOPRIL | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 1 | Online | 19-Nov-2021 | 1-Dec-2021 | NA | NA | In USP Captopril Disulfide RS: Change L-Proline, 1,1ʹ-[dithiobis(2-methyl-1-oxo-3,1-propanediyl)]bis-[S-(R*,R*)]-. to: (2ʹS)-[(2S,2ʹS)-3,3ʹ-Disulfanediylbis(2-methylpropanoyl)]di-L-proline. |
ELEUTHERO ROOT AND RHIZOME DRY EXTRACT | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 1 | Online | 19-Nov-2021 | 1-Dec-2021 | NA | NA | Change USP Eleutheroside B RS β-D-Glucopyranoside, 4-(3-hydroxy-1-propenyl)-2,6-dimethoxyphenyl. C17H24O9 372.37 USP Eleutheroside E RS β-D-Glucopyranoside, (tetrahydro-1H,3H-furo(3,4-c)furan-1,4-… Read More |
DACARBAZINE FOR INJECTION | IMPURITIES/Organic Impurities | USPNF 2021 ISSUE 1 | Online | 19-Nov-2021 | 1-Dec-2021 | NA | NA | Delete Diluent: 4.0 mg/mL of citric acid in water |
ELEUTHERO ROOT AND RHIZOME | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 1 | Online | 19-Nov-2021 | 1-Dec-2021 | NA | NA | Change USP Eleutheroside B RS β-D-Glucopyranoside, 4-(3-hydroxy-1-propenyl)-2,6-dimethoxyphenyl. C17H24O9 372.37 USP Eleutheroside E RS β-D-Glucopyranoside, (tetrahydro-1H,3H-furo(3,4-c)furan-1,4-… Read More |
ESTROPIPATE | CHEMICAL INFORMATION | USPNF 2021 ISSUE 1 | Online | 19-Nov-2021 | 1-Dec-2021 | NA | NA | Change 436.56 to: 436.57 |